CMS has proposed reducing Medicare Part B reimbursement for 340B-acquired drugs to ASP -33.4%
It’s not yet entirely clear if patients who develop immunotherapy-related endocrine dysfunction will regain full endocrine function when immunotherapy is stopped
The TV special heralded GLP-1 agonist medications as a miracle tool for many people that could put a dent in Americas obesity epidemic, citing that Nearly one in three Americans are overweight and close to 40 percent qualify as obese. Were seeing double the amount of weight loss you can achieve with this class of medications compared to what weve had in our toolbox for the last several decades, in combination of course with a healthy lifestyle, said Amanda Velazquez, MD, director of obesity medicine at Cedars-Sinai, in the TV special
Changes in patch appearance and size can be brought on by hormonal changes or inflammatory conditions
Biomarkers of oxidative or nitrosative stress were determined not only in the CNS tissue but also in plasma, urine, and CSF of ALS patients [9799]
Emerging non-invasive therapies, such as ultrasound stimulation of the vagus nerve, have shown promise in improving metabolic outcomes, including weight reduction, glucose homeostasis, and inflammatory modulation (Cotero et al
